| This article has been cited by |
| 1 | Management of skin adverse reactions in oncology | |
| Diva Silva,Ana Gomes,José MS Lobo,Vera Almeida,Isabel F Almeida |
| Journal of Oncology Pharmacy Practice.2020;26(7)1703 |
| [DOI] |
|
| 2 | Sorafenib induced hand-foot skin reaction at low dose | |
| VrutikaH Shah,BhagyashreeB Supekar,RajeshP Singh,JayeshI Mukhi |
| Indian Dermatology Online Journal.2020;11(6)997 |
| [DOI] |
|
| 3 | Sorafenib-induced hand-foot skin reaction | |
| Madhvi Trivedi,RajeshDutt Mehta,BhikamChand Ghiya,Prasoon Soni |
| Journal of Radiation and Cancer Research.2022;0(0)0 |
| [DOI] |
|
| 4 | Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management | |
| B. McLellan,F. Ciardiello,M.E. Lacouture,S. Segaert,E. Van Cutsem |
| Annals of Oncology.2015;26(10)2017 |
| [DOI] |
|
